The deal is designed to sharpen IFF’s focus on its higher-growth and higher-margin businesses while strengthening its balance sheet and enhancing long-term shareholder value.
The facility is designed to deepen material understanding, optimize crop quality, and advance sustainable sourcing right at the origin of production.
The company reported net sales of US$2.74 billion, marking a 4% decline from the prior year on a reported basis.
The transaction aligns with Bunge’s strategy to optimize its ingredients portfolio, aiming to offer a more diverse range of solutions to customers.
Despite a challenging market environment, IFF maintained its full-year guidance.